https://www.avient.com/news/specialty-healthcare-polymer-solutions-be-showcased-avient-mdm-west-2024
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/news/avient-and-virginia-tech-collaborate-industrial-design-students-challenged-automotive-aftermarket-part-competition
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/news/polyone-expands-healthcare-portfolio-biomerics’-specialty-medical-solutions
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/news/specialty-and-sustainable-healthcare-material-solutions-avient-medtec-china-2023
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/news/avient-highlight-achievements-global-growth-latest-innovations-plastindia-2023
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/news/avient-showcases-new-sustainable-solutions-and-recent-compliance-certifications-itma-2023
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/news/medtec-china-2024-avient-announces-healthcare-tpu-manufacturing-expansion
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/news/plastics-and-rubber-thailand-2024-include-avients-showcase-specialty-and-sustainable-materials
Apr 03, 2025
Feb 13, 2025
Feb 10, 2025
https://www.avient.com/sites/default/files/2021-11/avnt-november-investor-meetings.pdf
We are Avient.
6
B ET T E R TO G E TH E R : P O LYO NE A N D
C L A R I A N T C O LO R
Key Financial Data (1)
2021E Sales $4.75 billion
2021E EBITDA $580 million
87% of EBITDA from specialty applications
(1) As of October 28, 2021 webcast
Synergies
($ millions)
Three-Year
Estimate
Administrative $ 20
Sourcing 30
Operational 25
Total Synergies $ 75
7
C L A R I A N T C O S T S Y N ERG I E S
• On-track to realize $50 million of expected
synergies in 2021 – up from earlier estimate of $35
million
• Relentless focus on guiding principles for
acquisition integration: safety first, employee
collaboration and exceeding customer expectations
• Future revenue synergies in excess of $50 million
by 2025 are not part of these estimates and
represent additional growth over the long term
8
• Barrier technology
• Functional additives
• Processing aids
• Flame retardants
• Light-weighting
additives
Complementary
Technologies
• Clariant’s approved
formulations and
certified facilities
• Legacy PolyOne’s
leading share in
distribution channels
Healthcare
Solutions
• Clariant’s position
in SE Asia,
Latin America,
Germany & Italy
• Legacy PolyOne’s
position in U.S.,
Canada and China
Regional
Strengths
• Solutions with Avient’s
engineered materials
customers
• Avient’s distribution
channels
Segment
Cross-selling
C O M P L E M E NTA RY T E C H N O LOG I E S A N D
C U S TO M ER S D R I V E R E V E N U E S Y N E RG I E S
Revenue synergy opportunities in excess of $50M by 2025
The complementary aspects of our combined businesses are unquestionable.
This
innovation drives performance and is
reflective of consistent, strategic
investments in technology and people
Clariant Color business
acquired July 1, 2020
1
1
2
3
5
7
7
7
9
10
30
40
14
25
13
22
35
9
19
13
18
41
Current Additional share needed to reach 2025 target
B R A N D O W N E R S C O M M I T T E D TO I N C R E A S I N G
U S E O F R E C YC L E D M AT E R I A L S
14
Brand Owner 1
Brand Owner 3
Brand Owner 2
Brand Owner 7
Brand Owner 4
Brand Owner 10
Brand Owner 6
Brand Owner 11
Brand Owner 5
Brand Owner 8
Brand Owner 9
Brand Owner 12
Brand Owner 13
Percent recycled plastic used:
(examples and not exhaustive)
(1)
(1) Latest year reported.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
We are Avient.
6
B ET T E R TO G E TH E R : P O LYO NE A N D
C L A R I A N T M A S T ER BATC H
Key Financial Data (1)
2021E Sales $4.3 billion
2021E EBITDA $560 million
2021E Free Cash Flow $275 million
88% of EBITDA from specialty applications
(1) As of April 30, 2021 webcast
Synergies
($ millions)
Three-Year
Estimate
Administrative $ 20
Sourcing 30
Operational 25
Total Synergies $ 75
7
C L A R I A N T C O S T S Y N ERG I E S
• On-track to realize $45 million of expected
synergies in 2021 – up from previous estimate of
$35 million
• Relentless focus on guiding principles for
acquisition integration: safety first, employee
collaboration and exceeding customer expectations
• Future revenue synergies in excess of $50 million
by 2025 are not part of these estimates and
represent additional growth over the long term
8
• Barrier technology
• Functional additives
• Processing aids
• Flame retardants
• Light-weighting
additives
Complementary
Technologies
• Clariant’s approved
formulations and
certified facilities
• Legacy PolyOne’s
leading share in
distribution channels
Healthcare
Solutions
• Clariant’s position
in SE Asia,
Latin America,
Germany & Italy
• Legacy PolyOne’s
position in U.S.,
Canada and China
Regional
Strengths
• Solutions with Avient’s
engineered materials
customers
• Avient’s distribution
channels
Segment
Cross-selling
C O M P L E M E NTA RY T E C H N O LOG I E S A N D
C U S TO M ER S D R I V E R E V E N U E S Y N E RG I E S
Revenue synergy opportunities in excess of $50MM by 2025
The complementary aspects of our combined businesses are unquestionable.
We estimate in excess of $50 million dollars of new application sales by 2025, exclusively generated from the joining of our portfolios and technology teams.